Innovid (NYSE:CTV - Get Free Report)'s stock had its "buy" rating reaffirmed by analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $3.00 price target on the stock. Needham & Company LLC's price target would indicate a potential upside of 66.20% from the company's previous close.
Separately, Morgan Stanley upped their target price on shares of Innovid from $2.20 to $2.50 and gave the stock an "equal weight" rating in a report on Tuesday, July 23rd.
View Our Latest Report on CTV
Innovid Trading Down 0.3 %
Shares of CTV stock traded down $0.01 during mid-day trading on Wednesday, reaching $1.81. 412,041 shares of the company's stock traded hands, compared to its average volume of 339,728. The firm has a 50 day moving average price of $1.83 and a two-hundred day moving average price of $1.90. Innovid has a 12 month low of $1.05 and a 12 month high of $2.58.
Hedge Funds Weigh In On Innovid
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. FMR LLC increased its holdings in shares of Innovid by 590.2% in the 3rd quarter. FMR LLC now owns 15,413 shares of the company's stock worth $28,000 after buying an additional 13,180 shares during the last quarter. SG Americas Securities LLC bought a new stake in Innovid during the first quarter worth approximately $56,000. Lazard Asset Management LLC purchased a new stake in Innovid during the first quarter valued at approximately $58,000. American Century Companies Inc. purchased a new stake in Innovid during the second quarter valued at approximately $61,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of Innovid in the 2nd quarter valued at approximately $81,000. Institutional investors own 25.46% of the company's stock.
About Innovid
(
Get Free Report)
Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies.
Read More
Before you consider Innovid, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innovid wasn't on the list.
While Innovid currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
